Comparing the current results to its competitors, Sintx Technologies Inc reported Revenue increase in the 2 quarter 2026 by 199.34 % year on year. The sales growth was above Sintx Technologies Inc 's competitors' average revenue growth of 12 %, achieved in the same quarter.
Sintx Technologies Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 44.41 %
Sintx Technologies Inc 's Comment on Competition and Industry Peers
The company is the sole provider of medical-grade silicon nitride-based products, holding FDA clearance for its silicon nitride Valeo products and the SiNAPTIC® Foot & Ankle Osteotomy Wedge System. Alternative biomaterials include PEEK, primarily manufactured by Invibio; BIOLOX® delta, a traditional oxide ceramic produced by CeramTec; allograft bone; metals; and coated metals. Key competitors in the medical device market using various biomaterials are Medtronic, Inc.; DePuy Synthes Companies (part of Johnson & Johnson); Stryker Corporation; and Zimmer Biomet, Inc. These companies source ceramic components on an OEM basis from manufacturers such as CeramTec, Kyocera, and CoorsTek, Inc. In the antipathogenic market segment, main competitors include BactiGuard and MicroBan. Competition is based on technology, innovation, product quality, and customer acceptance. Principal competitors possess substantially greater financial, technical, marketing, and manufacturing resources, which may enable them to develop products that could render the company's offerings non-competitive. The company's success depends on its ability to develop innovative products with advanced performance features.
Orthopediatrics Corp is a medical device company specializing in orthopedic implants and instruments for children with orthopedic conditions. Their business model revolves around designing, manufacturing, and distributing innovative pediatric orthopedic products to healthcare providers worldwide. By focusing solely on pediatric patients, they aim to address the unique needs and challenges in this niche market, providing quality solutions for improved pediatric orthopedic care.
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
Monogram Orthopaedics Inc. operates on a specialized business model focused on developing and manufacturing innovative orthopedic medical devices. With a strong emphasis on research and development, they design cutting-edge solutions to address various musculoskeletal conditions. The company collaborates with healthcare professionals to test and refine their products, ensuring their efficacy and safety for patients.
Orthofix Medical Inc is a company that focuses on developing and selling medical devices and orthopedic solutions to healthcare providers and patients.
Sources:
Sintx Technologies Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Sintx Technologies Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
